Cytomedix to Host Third Quarter 2010 Financial Results Conference Call on Thursday, November 11, 2010
November 02, 2010 08:59 ET
|
Cytomedix, Inc.
GAITHERSBURG, Md., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Showcase AutoloGel System at the 18th Annual Scientific Meeting of the International Society of Hair Restoration Surgery
October 20, 2010 08:15 ET
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Secures $13 Million in Committed Funding
October 08, 2010 08:30 ET
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Announces AutoloGel System Oral Presentation at the Academy of Spinal Cord Injury Professionals' Annual Meeting
September 23, 2010 09:13 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Announces AutoloGel System Poster Presentation at the Symposium on Advanced Wound Care (SAWC) Fall 2010
September 23, 2010 09:04 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present at Rodman & Renshaw 12th Annual Global Investment Conference
September 07, 2010 08:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Reports Second Quarter 2010 Financial Results
August 16, 2010 17:27 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 16, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Host Second Quarter 2010 Financial Results Conference Call on Tuesday, August 17, 2010
August 09, 2010 10:05 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
Cytomedix Appoints Patrick Vanek as Vice President of Operations
July 28, 2010 10:47 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., July 28, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Positive Data From Study of the AutoloGel System to Treat Complex Chronic Wounds Published in Ostomy Wound Management
June 16, 2010 09:23 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., June 16, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...